ELLEN MATTESON: Open Payments
NPI 1427320282 · WESTPORT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 25 payments from 15 companies in 2025. Trend: 2023 $794 · 2024 $586 · 2025 $643
Food & beverage: $543Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $163 |
| UCB, Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Almirall LLC | 3 | $45 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $43 |
| Incyte Corporation | 2 | $42 |
| Arcutis Biotherapeutics, Inc. | 1 | $40 |
| Amgen Inc. | 2 | $39 |
| ABBVIE INC. | 1 | $29 |
| Organon LLC | 1 | $28 |
Products named: TREMFYA, Bimzelx, Klisyri, Winlevi, OPZELURA, Zoryve, OTEZLA, COSENTYX.
Industry payments across CT — which companies pay providers there.
